Geron Corp (GERN) Stock Price, Quote, News & History

GERNNASDAQ
$1.36
0.097.09%
At close: Jul 2, 5:00 PM EST
$1.36
N/A
After Hours: Jul 2, 7:47 PM EST
Loading...

Key Statistics

Open
$1.29
Close
$1.36
Volume / Avg.
10.55M / 15.85M
Day Range
$1.27 - $1.36
52 Wk Range
1.04 - 2.01
Market Cap
$872.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
11.68%
Days to Cover
5.89

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-125.96M
Investing Cash Flow (TTM)
106.66M
Financing Cash Flow (TTM)
4.44M
Free Cash Flow (TTM)
-126.27M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-14.86M

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$682.13M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.29
PB Ratio (TTM)
3.53
Earnings Yield % (TTM)
-8.73%
Earnings Yield % (FWD)
-1.59%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.36

Company Debt

Total Debt
$119.83M
LT Debt
$119.83M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$68.90M
Debt to Equity
0.53
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.29
Close
$1.36
Volume / Avg.
10.55M / 15.85M
Day Range
$1.27 - $1.36
52 Wk Range
1.04 - 2.01
Market Cap
$872.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
11.68%
Days to Cover
5.89

About

Sector
Health Care
Industry
Biotechnology
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Geron (GERN) stock?

A

You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Geron (GERN) competitors?

A

There are no as such competitors for Geron.

Q

What is the forecast, or price target, for Geron (GERN) stock?

A

Geron has a consensus price target of $5.38.

Q

What is the current price for Geron (GERN)?

A

The stock price for Geron (NASDAQ: GERN) is $1.36 last updated July 2, 2026 at 7:47 PM EDT.

Q

Does Geron (GERN) pay a dividend?

A

There are no upcoming dividends for Geron.

Q

When is Geron (NASDAQ:GERN) reporting earnings?

A

Geron does not have any upcoming earnings scheduled.

Q

Is Geron (GERN) going to split?

A

There is no upcoming split for Geron.

Q

What sector and industry does Geron (GERN) operate in?

A

Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.